Total Facility Solutions Opens Hygienic Fabrication Center
The fabrication facility will supply modular construction to the US life-science market.
Total Facility Solutions (TFS), a specialty contractor and services company focused on critical process infrastructure, completed the company’s first certified hygienic fabrication facility dedicated to the US life science market. Located in Burlington, North Carolina, the facility will provide hygienic and high-purity piping fabrication, stainless-steel skid fabrication, and field installations.
Off-site fabrication in a controlled environment has the benefits of cost-effectiveness and minimizing the number of people at the construction site area, which makes the site safer, notes the company. “Moving man-hours from a customer site to a regional fabrication facility helps us streamline our work,” said Joe Cestari, TFS president, in the press release. “Reducing congestion in the facility also reduces risk to safety, quality and schedule, all while meeting the stringent hygienic standards of the life science market.”
Source: Total Facility Solutions
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
